Longaeva Partners L.P.

Position in PACB — Pacific Biosciences Of California, Inc.

CIK 2054122 Chicago, IL

Position in PACB

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$3,558,628

New position

Shares Held

2,118,231

first reported quarter

Ownership

0.681%

of shares outstanding

% of Portfolio

0.10%

of 13F equity value

Holder Rank

#20

of 221 holders

Holding Since

Jun 2026

1 quarter on record

Voting authority Sole 0% Shared 100% None 0%

Healthcare · as of Jun 30, 2026

Longaeva Partners L.P. holds $98,991,444 across 12 Medical Devices names. PACB ranks #7 (3.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	GKOS	GLAUKOS Corp	236,192	$33,010,193
2	BSX	Boston Scientific Corp	540,836	$23,082,880
3	HAE	Haemonetics Corp	163,822	$12,286,650
4	ZBH	Zimmer Biomet Holdings, Inc.	98,054	$8,441,468
5	LMRI	Lumexa Imaging Holdings, Inc.	528,801	$5,964,875
6	BIO	Bio-Rad Laboratories, Inc.	14,639	$4,298,156
7	PACB	Pacific Biosciences Of California, Inc. This page	2,118,231	$3,558,628
8	SYK	Stryker Corp	7,859	$2,474,327

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$3,558,628	2,118,231	—	Shares	Other	2026-08-14
No filing history on record for this holder in this stock.